Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. Scientists resolved the mystery, showing the drug ‘hijacks’ a normal developmental pathway to trigger cancer cell death.
Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. Scientists resolved the mystery, showing the drug ‘hijacks’ a normal developmental pathway to trigger cancer cell death.